Form 4 for AMPH Amphastar Pharmaceuticals, Inc.
Accepted 2021-12-22 00:00:00 ET · period of report 2021-12-21 · accession 0001104659-21-152684 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-22 | 2021-12-21 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas | S - Sale+OE | $22.40 | -8,256 | 106.0K | -7% | -$184.9K |
| D | 2021-12-22 | 2021-12-21 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas | M - OptEx | $14.40 | +8,256 | 114.3K | +8% | +$118.9K |
| D | 2021-12-22 | 2021-12-21 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas | M - OptEx | $0.00 | -8,256 | 108.6K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-21 | S | D | 8,256 | $22.40 | 106,042 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-21 | M | A | 8,256 | $14.40 | 114,298 | D | — | — | |
| 3 | Derivative | Employee Stock Option (right to buy) | 2021-12-21 | M | D | 8,256 | $0.00 | 108,553 | D | $14.40 · — to 2024-04-21 | 8,256 Common Stock | (F2) Shares subject to the option are fully vested and immediately exercisable. |